Pausing GLP-1 drugs before surgery: new study aims to find the sweet spot

NCT ID NCT07623148

Completed Knowledge-focused Sponsor: Wonkwang University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 06, 2026 · Updated 7 times

Summary

This study watches 186 adults who take GLP-1 drugs (like Ozempic) and are having planned surgery. Researchers use a stomach ultrasound to check how much food or liquid is left in the stomach after stopping the drug for different lengths of time. The goal is to see if longer pauses lead to emptier stomachs, which may lower the risk of complications during anesthesia.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help doctors give clearer guidance on when to pause GLP-1 drugs before surgery to reduce the risk of food or liquid remaining in the stomach.
What could go wrong: This is an observational study, not a treatment trial. It only measures stomach contents with ultrasound and does not test any new drug or intervention. Results may not apply to all patients or surgeries.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DELAYED GASTRIC EMPTYING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroparesis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DELAYED GASTRIC EMPTYING RESIDUAL GASTRIC CONTENTS

Contacts and locations

Locations

Wonkwang University School of Medicine Hospital

Iksan, Jeonbuk-do, 54538, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.